About Elanco

Galliprant® (grapiprant tablets) is made by Elanco, a global, innovation-driven company that develops and markets products to improve animal health in more than 75 countries. Established in 1954, Elanco Animal Health enables veterinarians to help pets live longer, healthier, higher quality lives.

Elanco develops and delivers products for consumers, animals and the environment. All of our products conform to rigorous regulatory oversight and quality assurance systems that are built on consistency, dependability, accountability and traceability.


Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.

Important Safety Information

Not for use in humans. Keep out of reach of children and pets. Monitoring is recommended if used long term. Should not be used in dogs who are allergic to grapiprant or with other anti-inflammatory drugs. The safe use of Galliprant has not been studied in dogs younger than 9 months of age and less than 8 pounds, breeding, pregnant or lactating dogs, or dogs with heart disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite and tiredness. View full product label for complete safety information or contact your veterinarian.